Testicular hypofunction

E4_TESTICHYPO

testicular disease: A non-neoplastic or neoplastic disorder affecting the testis. Representative examples include torsion, infarction, germ cell tumor, sex cord-stromal tumor, lymphoma, and leukemia.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only males	226837
2. Check conditions None	226837
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E29.1# Hospital discharge: ICD-9 — 257[1-2] Hospital discharge: ICD-8 — 2571 Cause of death: ICD-10 — E29.1# Cause of death: ICD-9 — 257[1-2] Cause of death: ICD-8 — 2571 KELA reimbursements: KELA codes — ANY KELA reimbursements: ICD-10 — E29.1# 3 out of 7 registries used, show all original rules.	1175
4. Check minimum number of events None	1175
5. Include endpoints None	1175
6. Filter based on genotype QC (FinnGen only)	1175

Control definitions (FinnGen only)

Control exclude: E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E29
Name in latin: Hypofunctio testium

NAME	E4_TESTICHYPO
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E291
HD_ICD_9	257[1-2]
HD_ICD_8	2571
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E291
COD_ICD_9	257[1-2]
COD_ICD_8	2571
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	ANY
KELA_REIMB_ICD	E291
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Testicular hypofunction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Testicular hypofunction, drug-induced

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4793	-	4793
Only index persons	4698	-	4698
Unadjusted period prevalence (%)
Whole population	0.13	-	0.13
Only index persons	0.18	-	0.18
Median age at first event (years)
Whole population	-	-	48.75
Only index persons	-	-	48.71

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1175	-	1175
Unadjusted period prevalence (%)	0.52	-	0.52
Median age at first event (years)	51.77	-	51.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1039: Matched controls
10390

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

175.9

323.0

911

402

E29.1

ICD-10 Finland

Testicular hypofunction

1303.7

323.0

871

121

Kela drug reimbursment

Severe hypofunction of sexual glands

875.8

323.0

389

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

75.9

142.9

161

Y28

ICPC

Limited function/disability (Y)

74.5

84.0

A50

ICPC

General and Unspecified, Medication/prescr/renewal

13.7

75.1

134

111

A55

ICPC

General and Unspecified, Local injection/infiltration

18.5

53.8

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

50.4

G47.3

ICD-10 Finland

Sleep apnoea

2.8

48.1

409

1934

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

9.6

39.1

G03GA01

ATC

chorionic gonadotrophin; parenteral

39.5

39.1

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

37.8

37.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.3

34.9

446

2523

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

6.3

32.0

150

T99

ICPC

Endocr/metab/nutrit disease other

19.3

31.6

R5140

NOMESCO Finland

Monitoring the use of the aid

3.0

30.7

197

744

KFC00

NOMESCO Finland

Unilateral orchiectomy

13.6

29.9

G04CA01

ATC

alfuzosin; oral

2.8

29.0

220

919

N48.4

ICD-10 Finland

Impotence of organic origin

5.5

27.5

163

N06AX11

ATC

mirtazapine; oral

2.2

27.1

349

1923

M01AH05

ATC

etoricoxib; oral

2.0

25.9

651

4707

H03AA01

ATC

levothyroxine sodium; systemic

3.1

25.8

158

572

N02AX02

ATC

tramadol; systemic, rectal

2.0

25.5

463

2935

N06AB10

ATC

escitalopram; oral

2.5

24.8

234

1096

N03AX16

ATC

pregabalin; oral

2.4

24.5

256

1267

A02BC05

ATC

esomeprazole; systemic

2.0

23.5

402

2464

N05BA04

ATC

oxazepam; oral

2.3

22.5

240

1192

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

22.4

433

2770

N06AX12

ATC

bupropion; oral

3.5

21.9

109

339

A02BC02

ATC

pantoprazole; systemic

1.9

21.8

607

4419

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

21.7

505

3444

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

21.7

431

2775

E29.9

ICD-10 Finland

Testicular dysfunction, unspecified

51.1

21.2

N05AH04

ATC

quetiapine; oral

2.3

20.9

213

1033

J01DB01

ATC

cefalexin; oral

2.1

20.8

844

7002

N62

ICD-10 Finland

Hypertrophy of breast

10.1

20.7

R03AC02

ATC

salbutamol; inhalant

1.9

20.1

484

3311

N03AX12

ATC

gabapentin; oral

2.5

20.0

174

775

T55

ICPC

Metabolic, Local injection/infiltration

58.7

20.0

N05CF02

ATC

zolpidem; oral

2.4

19.9

197

936

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

19.8

170

749

Q98.0

ICD-10 Finland

Klinefelter syndrome karyotype 47,XXY

75.0

19.8

R53

ICD-10 Finland

Malaise and fatigue

2.5

19.6

177

803

J01MA02

ATC

ciprofloxacin; systemic

1.9

19.4

384

2442

N06AX21

ATC

duloxetine; oral

2.9

19.3

127

479

J01CA04

ATC

amoxicillin; systemic

2.0

19.3

806

6625

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

11.3

19.3

J01FA10

ATC

azithromycin; systemic

1.8

19.2

566

4122

N06AX16

ATC

venlafaxine; oral

2.5

19.1

169

759

M03BX02

ATC

tizanidine; oral

1.8

18.9

656

5031

N05CF01

ATC

zopiclone; oral

2.0

18.8

296

1725

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

18.7

186

886

N06AX26

ATC

vortioxetine; oral

3.5

18.5

269

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

18.2

287

1671

N46

ICD-10 Finland

Male infertility

4.9

17.9

126

-50

ICPC

Medication/prescr/renewal

4.6

17.7

141

D75.1

ICD-10 Finland

Secondary polycythaemia

12.7

17.7

N06AB04

ATC

citalopram; systemic

2.1

16.9

207

1082

R01AD09

ATC

mometasone; nasal

1.8

16.8

428

2930

M01AE02

ATC

naproxen; oral, rectal

1.7

16.5

543

4016

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

16.5

285

1705

M54.5

ICD-10 Finland

Low back pain

1.9

16.4

324

2033

N02BE01

ATC

paracetamol; systemic, rectal

1.9

16.2

817

6882

M01AB05

ATC

diclofenac; systemic, rectal

1.7

16.0

695

5566

A02BC03

ATC

lansoprazole; oral

1.9

15.9

260

1518

XKD00

NOMESCO Finland

Uroflowmetry

2.1

15.9

196

1025

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

15.7

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

15.7

WX723

NOMESCO Finland

CPAP therapy

3.4

15.5

240

J01AA02

ATC

doxycycline; systemic

1.8

15.4

745

6123

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

16.3

15.3

R06AX27

ATC

desloratadine; oral

1.9

15.3

250

1459

H02AB06

ATC

prednisolone; systemic

1.7

15.2

412

2852

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

15.1

498

3648

T28

ICPC

Limited function/disability (T)

10.3

15.0

R01AD12

ATC

fluticasone furoate; nasal

1.9

14.9

282

1736

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

3.5

14.8

210

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.2

14.7

139

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

14.7

137

629

R06.0

ICD-10 Finland

Dyspnoea

2.0

14.7

208

1147

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

14.5

100

388

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

14.5

274

1679

Q98.4

ICD-10 Finland

Klinefelter syndrome, unspecified

152.0

14.5

L02BA01

ATC

tamoxifen; oral

27.6

14.3

H02AB09

ATC

hydrocortisone; systemic

7.5

14.3

R01AD08

ATC

fluticasone; nasal

1.8

14.3

280

1740

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

14.2

101

398

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

14.1

166

850

SPAT1262

SPAT

Handing over of treatment supplies

2.0

13.8

191

1045

N06AB03

ATC

fluoxetine; oral

2.5

13.8

114

489

L02BG04

ATC

letrozole; oral

13.8

SPAT1254

SPAT

Administration of medicine

2.4

13.7

127

580

N04BC05

ATC

pramipexole; oral

3.3

13.7

218

R51.80

ICD-10 Finland

Headache

2.3

13.5

126

578

Y50

ICPC

Male Genital, Medication/prescr/renewal

26.1

13.4

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.3

13.3

118

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

13.3

141

684

R06.5

ICD-10 Finland

Mouth breathing

2.2

13.3

137

660

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

13.2

253

1551

E66.00

ICD-10 Finland

Metabolic syndrome

2.9

13.2

309

L02BG03

ATC

anastrozole; oral

40.6

13.2

E66.01

ICD-10 Finland

Obesity due to excess calories

2.8

13.1

318

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

13.0

290

1867

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

13.0

209

1206

E0000UV

ATC

1.7

12.9

331

2223

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

12.9

233

1399

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

12.7

500

3779

J02AC01

ATC

fluconazole; systemic

1.9

12.7

193

1090

J01FA06

ATC

roxithromycin; oral

1.7

12.5

355

2454

M79.6

ICD-10 Finland

Pain in limb

1.7

12.5

291

1896

E89.5

ICD-10 Finland

Postprocedural testicular hypofunction

131.5

12.5

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

12.3

158

835

A02BC01

ATC

omeprazole; systemic

1.8

12.2

233

1424

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.9

12.2

200

1160

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

16.1

12.2

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.4

12.1

108

484

T50

ICPC

Metabolic, Medication/prescr/renewal

18.3

12.1

S55

ICPC

Skin, Local injection/infiltration

27.0

12.1

UKC02

NOMESCO Finland

Cystoscopy

2.0

11.9

160

860

F51.0

ICD-10 Finland

Nonorganic insomnia

2.2

11.8

125

607

J01MA12

ATC

levofloxacin; systemic

1.9

11.8

176

986

C09CA06

ATC

candesartan; oral

1.9

11.8

200

1174

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

11.7

380

WX780

NOMESCO Finland

Remote monitoring CPAP

2.8

11.7

292

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

11.6

232

1434

KFH50

NOMESCO Finland

Insertion of prosthetic replacement for testis

23.2

11.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

11.6

174

975

H02AB04

ATC

methylprednisolone; systemic

2.2

11.6

127

626

R06AE07

ATC

cetirizine; oral

1.6

11.5

365

2585

E30.09

ICD-10 Finland

Delayed puberty NOS

+∞

11.5

N05BA12

ATC

alprazolam; oral

2.3

11.5

108

497

N05CD07

ATC

temazepam; oral

2.3

11.4

105

475

AA1AD

NOMESCO Finland

CT of head and brain

1.8

11.3

208

1252

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

11.3

296

1987

R52.2

ICD-10 Finland

Other chronic pain

4.4

11.3

M01AC06

ATC

meloxicam; systemic, rectal

1.7

11.2

318

2181

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

11.2

245

1557

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

11.1

319

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.5

11.1

151

XW000

NOMESCO Finland

Bone marrow biopsy

3.6

11.0

141

J05AB11

ATC

valaciclovir; oral

2.3

11.0

105

485

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

10.9

404

2968

C07AA05

ATC

propranolol; systemic

1.9

10.8

165

930

P01AB01

ATC

metronidazole; oral, rectal

1.7

10.8

279

1863

L03

ICPC

Low back symptom/complaint

1.8

10.8

192

1141

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

10.8

109

519

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.7

10.7

296

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

10.6

197

1189

M04AA01

ATC

allopurinol; systemic

2.1

10.4

123

627

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

10.3

177

C62.12

ICD-10 Finland

Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma

19.0

10.3

N06AB06

ATC

sertraline; oral

2.1

10.2

112

553

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

10.2

212

Y05

ICPC

Scrotum/testis sympt/compl other

5.5

10.2

WVA30

SPAT

3.8

10.1

115

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

10.1

200

1229

127

Kela drug reimbursment

Transplant complication

5.2

10.0

E66.8

ICD-10 Finland

Other obesity

3.0

10.0

197

E29

ICD-10 Finland

Testicular dysfunction

40.5

10.0

A98

ICPC

Health maint/preventive medicine

2.3

9.9

987

9252

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

9.7

252

1673

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

9.7

217

1383

M48.0

ICD-10 Finland

Spinal stenosis

2.2

9.7

101

486

OAB72

NOMESCO Finland

Weight control and weight loss guidance

13.5

9.7

E22.1

ICD-10 Finland

Hyperprolactinaemia

55.5

9.7

S01GX01

ATC

cromoglicic acid; ophthalmic

1.9

9.7

145

811

N06BA04

ATC

methylphenidate; oral

4.1

9.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

9.5

435

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

9.5

158

914

N05BA01

ATC

diazepam; systemic, rectal

2.0

9.5

125

663

C07AB07

ATC

bisoprolol; oral

1.6

9.4

371

2738

H01AC01

ATC

somatropin; parenteral

100.9

9.4

Q53.2

ICD-10 Finland

Undescended testicle, bilateral

+∞

9.4

2572A

ICD-9 Finland

Testicular dysfunction, Other testicular hypofunction

+∞

9.4

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

+∞

9.4

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

+∞

9.4

J01FA09

ATC

clarithromycin; systemic

1.6

9.4

276

1896

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.8

9.3

226

C10AA07

ATC

rosuvastatin; oral

1.7

9.3

222

1441

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

9.3

360

J05AB01

ATC

aciclovir; systemic

1.8

9.3

156

909

N06AA12

ATC

doxepin; systemic

2.9

9.2

191

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

9.2

211

1350

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

9.1

343

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

9.1

146

836

R06AX22

ATC

ebastine; oral

1.9

9.1

137

768

SPAT1310

SPAT

Counselling related to known health issue

1.6

9.1

247

1661

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

37.0

9.0

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

9.0

189

R50.9

ICD-10 Finland

Fever, unspecified

1.9

8.9

141

802

M02AA07

ATC

piroxicam; topical

1.6

8.9

290

2041

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

12.7

8.9

UDC00

NOMESCO Finland

Ear microscopy

2.4

8.8

316

J01FF01

ATC

clindamycin; systemic

1.6

8.8

257

1757

S50

ICPC

Skin, Medication/prescr/renewal

8.7

8.8

Y08

ICPC

Sexual function sympt/compl male

9.6

8.8

P06

ICPC

Sleep disturbance

2.1

8.8

467

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

8.7

257

1762

C62.19

ICD-10 Finland

Malignant tumor of the descending testicle, other or undetermined histology

50.4

8.7

N03AX09

ATC

lamotrigine; oral

2.7

8.7

221

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

8.7

153

906

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

8.7

299

2133

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

8.5

202

1306

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.5

8.5

111

T29

ICPC

Endocr/metab/nutr sympt/compl other

5.0

8.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

8.5

349

J01AA04

ATC

lymecycline; systemic

1.9

8.5

118

642

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

8.4

489

G04CA02

ATC

tamsulosin; oral

1.6

8.4

245

1674

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

8.4

452

E23.05

ICD-10 Finland

Lack of TSH

90.7

8.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

8.4

361

2705

A02BC04

ATC

rabeprazole; oral

2.3

8.4

359

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

+∞

8.3

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

+∞

8.3

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.6

8.3

234

1582

N06AX22

ATC

agomelatine; oral

4.1

8.3

Y99

ICPC

Genital disease male other

9.5

8.3

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.3

8.2

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.6

8.2

235

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

8.2

264

X58

ICD-10 Finland

Exposure to other specified factors

1.7

8.1

164

1011

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

8.1

125

705

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

8.0

217

1451

E29.8

ICD-10 Finland

Other testicular dysfunction

22.2

8.0

M25.5

ICD-10 Finland

Pain in joint

1.6

8.0

224

1513

C03CA01

ATC

furosemide; systemic

1.7

8.0

165

1025

R01AD01

ATC

beclometasone; nasal

1.8

8.0

135

787

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

8.0

369

2804

75210

ICD-8 Finland

Congenital anomalies of genital organs, Undescended testicle

4.3

7.9

N18.8

ICD-10 Finland

Other chronic renal failure

3.8

7.9

L17

ICPC

Foot/toe symptom/complaint

1.7

7.9

176

1117

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

7.9

286

F32.1

ICD-10 Finland

Moderate depressive episode

2.8

7.9

187

R02

ICPC

Shortness of breath/dyspnoea

2.1

7.8

412

Z01.2

ICD-10 Finland

Dental examination

1.5

7.8

353

2666

L03AA02

ATC

filgrastim; parenteral

4.1

7.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

7.7

133

779

H05BX01

ATC

cinacalcet; oral

45.3

7.7

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.3

7.6

317

R03BA08

ATC

ciclesonide; inhalant

2.3

7.6

306

L08

ICPC

Shoulder symptom/complaint

1.7

7.6

153

940

N41.1

ICD-10 Finland

Chronic prostatitis

2.7

7.6

186

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

25.2

7.6

R03BA05

ATC

fluticasone; inhalant

1.8

7.6

140

840

R03DC03

ATC

montelukast; oral

1.8

7.5

121

695

J01DA01

ATC

[U] cefalexin; systemic

1.4

7.5

555

4614

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

7.5

223

1527

P76

ICPC

Depressive disorder

2.5

7.5

242

SPAT1312

SPAT

General health counselling

1.6

7.5

239

1664

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

7.5

247

1736

M01AX17

ATC

nimesulide; oral

1.7

7.5

181

1173

SPAT1301

SPAT

No procedures

1.6

7.4

228

1573

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

80.6

7.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

7.4

153

946

C08CA01

ATC

amlodipine; oral

1.5

7.3

286

2086

N06AB05

ATC

paroxetine; oral

2.3

7.3

299

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

7.3

671

5796

G03GA05

ATC

follitropin alfa; parenteral

+∞

7.3

G03GA02

ATC

human menopausal gonadotrophin; parenteral

+∞

7.3

A02BA02

ATC

ranitidine; systemic

1.7

7.3

142

864

SPAT1263

SPAT

Sampling

1.5

7.2

333

2515

M54.2

ICD-10 Finland

Cervicalgia

2.3

7.2

282

KFA00

NOMESCO Finland

Exploration of testis

8.0

7.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

7.1

170

1100

Z01.9

ICD-10 Finland

Special examination, unspecified

2.7

7.1

176

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

7.1

299

2218

7525A

ICD-9 Finland

Congenital anomalies of genital organs, Undescended testicle[RETENTIO TESTIS (CRYPTORCHISMUS)]

8.8

7.1

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.3

7.1

279

SPAT1325

SPAT

Vaccination

1.6

7.0

221

1532

WX110

NOMESCO Finland

Local anesthesy

1.4

7.0

654

5644

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

7.0

WX320

NOMESCO Finland

Spinalanesthesy

1.6

7.0

169

1095

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.8

7.0

160

R06AX13

ATC

loratadine; oral

1.8

7.0

116

671

J01EA01

ATC

trimethoprim; systemic

2.1

7.0

405

H02.3

ICD-10 Finland

Blepharochalasis

3.1

6.9

120

A04

ICPC

Weakness/tiredness general

2.1

6.9

370

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

6.9

171

1114

N06AA09

ATC

amitriptyline; systemic

2.2

6.9

336

T90

ICPC

Diabetes non-insulin dependent

1.6

6.9

201

1368

M54.1

ICD-10 Finland

Radiculopathy

2.9

6.9

143

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

6.8

136

M05BA04

ATC

alendronic acid; oral

3.2

6.8

110

C08CA02

ATC

felodipine; oral

2.2

6.8

303

R35

ICD-10 Finland

Polyuria

2.3

6.8

281

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

40.3

6.8

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.3

6.7

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

6.7

446

3606

L01

ICPC

Neck symptom/complaint

2.0

6.7

452

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

6.7

124

741

L04AA06

ATC

mycophenolic acid; systemic

4.0

6.7

R60.0

ICD-10 Finland

Localized oedema

2.1

6.7

384

A10BA02

ATC

metformin; oral

1.5

6.7

229

1621

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

6.6

524

4365

N06AX05

ATC

trazodone; oral

3.8

6.6

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.2

6.6

102

DHB50

NOMESCO Finland

Turbinoplasty

2.7

6.6

158

M79.1

ICD-10 Finland

Myalgia

1.9

6.6

511

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

6.5

381

Y29

ICPC

Genital symptom/complaint male other

5.1

6.5

R03AC03

ATC

terbutaline; inhalant

1.8

6.5

107

619

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

6.5

193

J01MA14

ATC

moxifloxacin; systemic

2.0

6.5

416

Y55

ICPC

Male Genital, Local injection/infiltration

70.3

6.4

D07AC13

ATC

mometasone; topical

1.5

6.4

238

1712

ZXA05

NOMESCO Finland

Left side

1.6

6.4

192

1313

205

Kela drug reimbursment

Chronic hypertension

1.6

6.4

189

1287

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.9

6.4

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

6.4

280

SBB10

NOMESCO Finland

Teeth copy

2.3

6.4

259

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

6.4

436

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

6.3

902

8369

L28

ICPC

Limited function/disability (L)

1.9

6.3

516

N02AA05

ATC

oxycodone; systemic

1.8

6.3

106

617

C08CA13

ATC

lercanidipine; oral

1.9

6.3

533

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

6.3

100

568

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

6.3

158

E23.03

ICD-10 Finland

Lack of ACTH

+∞

6.3

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.6

6.2

176

N04BC06

ATC

cabergoline; oral (dopamine agonists)

26.8

6.2

Y10

ICPC

Infertility/subfertility male

26.8

6.2

C62.1

ICD-10 Finland

Malignant neoplasm: Descended testis

26.8

6.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.6

6.2

177

M54

ICD-10 Finland

Dorsalgia

1.8

6.2

545

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

6.2

500

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

6.2

304

JN4BD

NOMESCO Finland

Extensive body CT

1.9

6.2

470

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.4

6.2

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

6.1

369

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

6.1

592

5080

M01AC01

ATC

piroxicam; systemic, rectal

1.8

6.1

106

624

R06AX18

ATC

acrivastine; oral

3.5

6.1

HMAK

NOMESCO Finland

1.8

6.1

104

609

A99

ICPC

Disease/condition unspecnature/site

2.2

6.1

284

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.6

6.1

190

1310

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

6.1

133

837

C02AC05

ATC

moxonidine; oral

2.7

6.1

147

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1002

1731

33.52

307.65

6.0

2.0

nmol/l

13.0

14.6

7.43

959

1587

(3009214) Lutropin [Units/volume] in Serum or Plasma

482

332

23.92

307.65

2.1

1.3

u/l

7.9

4.6

7.23

397

273

(3021387) Prolactin [Units/volume] in Serum or Plasma

340

244

19.20

307.65

1.6

1.3

mu/l

233.4

251.5

0.48

318

231

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

629

567

22.72

307.65

3.3

1.7

pmol/l

210.1

222.3

1.20

622

537

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

679

759

19.82

307.65

3.2

1.7

nmol/l

30.0

37.4

13.66

672

737

(3023323) Follitropin [Units/volume] in Serum or Plasma

204

119

20.53

254.62

2.0

1.3

iu/l

15.2

7.5

4.64

158

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1030

5959

6.90

128.64

4.8

3.8

ug/l

1.4

1.9

9.45

972

5462

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

20.80

113.07

1.8

1.6

nmol/l

0.1

0.26

(3036481) Cortisol [Moles/volume] in Serum or Plasma

287

731

4.87

106.84

2.2

2.0

nmol/l

347.6

370.4

1.46

270

680

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

152

238

7.19

94.96

1.8

1.4

pmol/l

103.9

202.8

0.36

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

810

4728

3.30

79.13

3.8

3.3

23.1

21.0

2.74

305

1832

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

11.52

79.06

1.7

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

916

5967

3.43

69.92

3.9

2.9

pmol/l

14.4

14.8

4.56

861

5463

(3001122) Ferritin [Mass/volume] in Serum or Plasma

575

2997

2.80

64.75

3.2

2.5

ug/l

163.1

210.9

3.92

542

2821

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

15.67

61.70

1.4

1.2

u/l

20.0

8.0

3.11

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

624

3509

2.66

58.69

3.0

2.5

ug/l

0.6

0.7

0.54

346

1961

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

21.19

46.23

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1015

7768

3.25

44.82

4.8

3.5

mu/l

1.8

2.0

0.95

970

7176

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

9.11

44.31

6.7

4.8

u/l

4.4

35.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

7.56

42.70

1.5

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

901

6787

2.40

35.48

8.4

8.0

u/l

72.0

77.5

6.00

871

6491

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

483

2904

2.13

33.23

2.8

2.1

nmol/l

76.7

71.4

3.78

446

2672

(40765089) Chromosome analysis panel - Blood by G-banded

9.52

31.04

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

255

1253

2.32

28.34

3.3

2.5

umol/l

16.0

14.3

1.82

233

1177

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

641

4460

1.96

27.74

6.7

7.2

umol/l

12.5

12.8

0.20

617

4279

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

21.36

27.71

1.3

1.6

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

241

1169

2.34

27.53

3.2

2.5

g/l

2.4

2.3

2.49

216

1097

(3013826) Glucose [Moles/volume] in Serum or Plasma

721

5244

1.97

27.12

6.5

5.6

mmol/l

6.8

0.31

685

4987

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

9.92

26.86

5.0

4.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

230

1107

2.34

26.68

3.3

2.5

26.6

25.1

0.80

196

983

(40761536) Microorganisms panel - Urine sediment

159

652

2.66

25.97

4.0

3.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

134

4.66

25.22

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

145

579

2.72

24.92

5.8

4.0

mmol/l

1.2

0.57

129

522

(3002030) Lymphocytes/100 leukocytes in Blood

612

4311

1.88

24.29

7.4

6.9

28.4

28.0

0.44

587

4091

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1044

8878

2.58

23.93

6.5

5.1

mmol/mol

40.1

39.8

0.48

993

8418

(3013707) Erythrocyte sedimentation rate by Westergren method

818

6343

1.95

23.92

4.3

3.7

mm/h

7.9

9.4

3.07

789

5962

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1061

9093

2.72

23.90

15.5

11.6

ml/min/173m2

83.5

88.2

10.75

953

7633

(3015377) Calcium [Moles/volume] in Serum or Plasma

392

2400

1.95

23.87

3.1

3.6

mmol/l

2.3

0.02

352

2161

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1125

9962

4.04

23.77

5.8

4.5

mmol/l

2.7

2.9

7.12

1078

9394

(3019069) Monocytes/100 leukocytes in Blood

595

4177

1.86

23.65

7.7

7.2

9.0

0.05

572

3979

(3006504) Eosinophils/100 leukocytes in Blood

592

4150

1.86

23.63

7.4

6.9

3.0

0.04

569

3939

(3037467) Urinalysis macro (dipstick) panel - Urine

740

5565

1.89

23.62

4.0

3.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

526

3558

1.87

23.48

5.6

5.8

g/l

37.1

36.4

2.25

507

3358

(3021589) Normoblasts [#/volume] in Blood

572

3977

1.85

23.34

13.1

9.7

e9/l

0.1

0.0

0.51

519

3289

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

555

3833

1.85

23.05

9.4

7.9

mmol/l

1.2

1.45

443

3307

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

515

3480

1.85

22.90

8.9

7.4

mmol/l

1.2

0.93

480

3197

(3022096) Basophils/100 leukocytes in Blood

577

4041

1.84

22.83

7.5

7.0

0.7

0.40

555

3848

(3018010) Neutrophils/100 leukocytes in Blood

599

4246

1.84

22.77

7.1

6.7

56.2

56.8

0.57

579

4040

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

456

2970

1.87

22.75

2.0

1.8

pmol/l

96.2

94.2

0.48

261

1725

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

468

3074

1.87

22.73

3.6

3.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1115

9869

3.54

22.52

5.5

4.2

mmol/l

4.4

4.7

11.03

1070

9358

(3031040) Bacteria [#/volume] in Urine by Automated count

654

4796

1.82

21.92

4.0

3.3

e6/l

531.5

1354.9

—

(42870588) Differential panel, method unspecified - Blood

456

2999

1.85

21.85

7.1

6.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

137

567

2.60

21.84

2.0

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1110

9827

3.34

21.83

5.4

4.1

mmol/l

1.2

1.3

32.83

1068

9284

(3019550) Sodium [Moles/volume] in Serum or Plasma

1094

9614

3.00

21.71

19.9

14.8

mmol/l

139.6

139.7

1.36

1079

9398

(3013115) Eosinophils [#/volume] in Blood

634

4622

1.81

21.51

7.5

7.1

e9/l

0.2

0.28

585

4108

(3023103) Potassium [Moles/volume] in Serum or Plasma

1097

9669

3.03

21.35

20.1

14.8

mmol/l

4.0

2.56

1081

9449

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

176

3.85

21.24

1.3

1.2

u/l

13.9

35.3

1.86

153

(3006315) Basophils [#/volume] in Blood

617

4482

1.79

20.99

7.0

6.7

e9/l

0.0

0.15

567

3922

(3019198) Lymphocytes [#/volume] in Blood

631

4616

1.79

20.95

7.1

6.8

e9/l

2.0

0.05

586

4104

(40760892) CBC W Ordered Manual Differential panel - Blood

344

2092

1.91

20.88

5.0

4.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

42.47

20.50

1.7

1.3

—

(40761511) CBC panel - Blood by Automated count

1122

10051

3.58

20.49

17.9

11.6

—

(3001604) Monocytes [#/volume] in Blood

614

4476

1.78

20.44

7.0

6.7

e9/l

0.6

0.59

565

3911

(3018418) pH of Serum or Plasma

355

2194

1.89

20.43

5.8

4.3

7.4

0.24

115

425

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1086

9563

2.79

20.39

4.9

3.8

mmol/l

1.7

1.5

6.70

1043

9014

(3041096) Erythrocytes [Presence] in Urine by Automated

369

2319

1.86

20.09

3.1

2.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1146

10429

5.01

19.96

12.7

9.8

u/l

36.1

34.1

2.21

1121

10163

(3026782) Osmolality of Urine

275

1573

1.98

19.89

3.0

2.6

mosm/kgh2o

564.9

593.6

1.17

245

1344

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1074

9432

2.61

19.81

17.4

13.0

mg/l

21.6

25.2

3.53

904

7378

(3026493) Urate [Moles/volume] in Serum or Plasma

405

2639

1.82

19.50

2.9

2.6

umol/l

4704.5

5168.9

0.07

364

2391

(3021960) Folate [Moles/volume] in Serum or Plasma

273

1571

1.96

19.34

1.7

1.5

nmol/l

19.1

19.0

0.04

241

1381

(3002582) Erythrocytes [#/volume] in Urine

390

2519

1.82

19.29

3.7

3.0

e6/l

95.0

163.3

0.45

315

1951

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

470

3211

1.77

19.22

3.3

3.0

—

(3009261) Glucose [Presence] in Urine by Test strip

561

4034

1.75

19.15

3.4

2.9

estimate

0.0

0.32

140

677

(3035350) Ketones [Presence] in Urine by Test strip

558

4007

1.75

19.13

3.4

2.9

estimate

0.0

0.50

147

706

(3021601) Nitrite [Presence] in Urine by Test strip

557

3999

1.75

19.10

4.6

4.0

estimate

0.0

0.00

150

751

(3009508) Creatinine [Moles/volume] in Urine

435

2912

1.78

19.03

3.9

3.4

mmol/l

9.4

9.2

0.33

375

2503

(3001556) Androgen free Index in Serum or Plasma

28.34

18.77

1.4

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

285

1680

1.92

18.73

2.9

2.4

e6/l

2.1

2.7

1.33

255

1473

(3002385) Erythrocyte distribution width [Ratio]

941

7903

1.96

18.59

20.6

15.9

13.7

13.5

3.39

929

7731

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

494

3448

1.75

18.57

3.9

3.3

ng/l

31.6

45.9

1.22

348

2279

(3013650) Neutrophils [#/volume] in Blood by Automated count

668

5082

1.73

18.31

9.5

10.5

e9/l

4.4

4.2

0.36

611

4457

(3030467) Casts [#/volume] in Urine by Automated count

359

2300

1.81

18.01

3.7

2.9

e6/l

0.3

0.4

0.78

284

1733

(3012501) Base excess in Blood by calculation

202

3.40

17.99

4.3

4.4

mmol/l

2.2

2.1

0.19

126

(3027315) Oxygen [Partial pressure] in Blood

202

3.40

17.99

4.2

4.4

kpa

9.0

8.7

0.42

197

(3013290) Carbon dioxide [Partial pressure] in Blood

203

3.39

17.85

4.3

4.4

kpa

5.0

0.36

198

(3044889) 12 lead EKG panel

820

6636

1.78

17.76

4.0

3.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

470

3274

1.73

17.52

3.6

3.8

u/l

34.2

36.4

0.90

444

3097

(3003458) Phosphate [Moles/volume] in Serum or Plasma

213

1166

2.01

17.23

8.7

7.2

mmol/l

1.0

0.03

206

1116

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

282

1697

1.87

17.22

2.4

2.1

mg/l

3.2

2.9

1.06

238

1478

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

323

2.83

17.08

3.0

2.9

mg/l

1.4

0.06

308

(3013512) EKG study

355

2310

1.77

16.68

4.1

3.6

—

(3012516) Albumin [Mass/volume] in Urine

389

2601

1.74

16.60

3.7

3.3

mg/l

223.6

257.9

0.07

276

1787

(36304419) Bacteria [Presence] in Urine

350

2275

1.77

16.47

3.7

2.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

126

572

2.35

16.35

7.8

10.4

mmol/l

24.9

24.8

0.02

126

566

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

185

984

2.04

16.15

5.4

4.9

u/l

241.2

240.1

0.02

175

936

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1032

9086

2.12

15.94

5.0

4.0

mmol/l

6.1

6.0

0.37

965

8459

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

278

1707

1.82

15.75

1.3

1.2

u/ml

2.8

2.0

0.25

498

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

387

2616

1.71

15.70

2.7

2.3

u/l

289.1

362.1

0.53

366

2486

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

362

2403

1.73

15.68

1.8

1.7

mmol/l

1.8

1.6

2.13

305

2051

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

404

2775

1.69

15.38

2.6

2.8

u/l

55.7

59.1

0.85

377

2625

(3020682) Albumin/Creatinine [Ratio] in Urine

399

2739

1.69

15.19

4.8

4.1

mg/mmol

10.2

9.1

0.21

285

1888

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

883

7441

1.75

15.04

3.7

3.3

u/l

58.0

56.4

0.21

843

7107

(3018095) Leukocytes [#/volume] in Urine

407

2824

1.68

14.80

4.2

3.5

e6/l

96.8

61.7

0.38

327

2087

(3015736) pH of Urine

437

3092

1.66

14.71

3.0

2.8

—

5.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

255

1558

1.81

14.56

1.7

1.6

pmol/l

25114578.9

28762456.5

0.05

219

1349

(3032080) INR in Blood by Coagulation assay

485

3539

1.63

14.35

10.2

8.4

inr

1.2

0.96

201

1019

(1616796) Gas panel - Central venous blood

198

3.08

13.87

4.2

3.8

—

(1761868) Lipid panel - Serum or Plasma

573

4380

1.60

13.84

3.4

2.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

263

1661

1.75

13.29

1.7

1.5

g/l

2.4

2.7

2.03

190

1148

(3023368) Bacteria identified in Blood by Culture

352

2409

1.66

13.20

5.1

4.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

302

1991

1.70

13.04

2.1

1.8

mg/l

0.9

1.1

0.69

226

1471

(3004588) Protein electrophoresis panel - Serum or Plasma

105

487

2.27

12.92

2.1

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

272

1750

1.72

12.82

2.3

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

181

3.08

12.73

2.8

2.6

18.2

17.1

0.65

(3022145) Colonoscopy Study observation

175

988

1.91

12.71

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

350

2.48

12.65

3.2

3.7

pmol/l

4.8

4.7

0.39

322

(3026008) Bacteria identified in Urine by Culture

216

1317

1.78

12.24

3.1

2.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

157

867

1.94

12.17

3.7

3.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

434

2.29

12.12

4.8

4.4

ng/l

107.7

87.6

0.63

396

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

166

936

1.90

12.08

2.2

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

308

2084

1.65

11.89

3.7

3.3

estimate

0.0

0.07

142

689

(3007461) Platelets [#/volume] in Blood

1157

10944

4.73

11.79

27.1

18.3

e9/l

231.9

238.9

3.80

1145

10698

(3020630) Protein [Mass/volume] in Serum or Plasma

120

610

2.08

11.72

2.1

3.1

g/l

68.3

67.0

1.32

111

573

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

350

2.41

11.72

1.1

1.2

iu/ml

80.0

138.8

1.04

112

(3035941) MCH [Entitic mass]

1157

10950

4.70

11.65

26.9

18.2

30.4

30.5

1.63

1152

10822

(3024731) MCV [Entitic volume]

1157

10954

4.67

11.56

27.0

18.2

90.4

90.5

0.40

1152

10826

(3026361) Erythrocytes [#/volume] in Blood

1157

10955

4.66

11.54

27.1

18.3

e12/l

4.9

4.8

18.98

1143

10692

(3000963) Hemoglobin [Mass/volume] in Blood

1157

10956

4.66

11.52

27.3

18.4

g/l

149.6

145.0

16.35

1152

10823

(3021440) Promyelocytes/100 leukocytes in Blood

130

685

2.01

11.51

5.0

4.9

0.2

0.14

198

(3012095) Magnesium [Moles/volume] in Serum or Plasma

233

1478

1.72

11.43

5.0

4.4

mmol/l

0.8

0.53

224

1409

(3010813) Leukocytes [#/volume] in Blood

1157

10960

4.63

11.42

27.1

18.3

e9/l

6.9

6.7

0.52

1142

10698

(3025159) Blasts/100 leukocytes in Blood

124

645

2.03

11.38

4.8

4.9

0.2

0.1

0.10

170

(3017181) Myelocytes/100 leukocytes in Blood

135

726

1.97

11.28

5.0

4.8

1.6

0.8

1.53

217

(3019309) Folate [Moles/volume] in Red Blood Cells

196

1189

1.78

11.23

1.9

1.7

nmol/l

1262.5

1157.2

0.84

141

937

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

176

1034

1.83

11.22

2.3

2.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

317

2193

1.61

11.07

3.2

3.1

ng/l

838.0

1162.7

1.22

244

1822

(3002179) Metamyelocytes/100 leukocytes in Blood

125

668

1.97

10.63

4.7

4.5

0.8

0.5

0.84

169

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

117

3.32

10.33

5.6

3.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

113

590

2.01

10.26

2.1

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

107

551

2.04

10.09

3.2

mmol/l

1.4

1.5

0.10

408

(3005719) IgG [Mass/volume] in Serum or Plasma

138

777

1.88

10.04

2.9

2.4

g/l

10.0

10.8

1.31

118

706

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

180

2.80

9.87

4.0

54.2

55.6

0.38

180

(3009343) pH of Capillary blood

109

572

2.00

9.75

3.3

3.2

7.4

0.19

(40768804) Tissue Pathology biopsy report

395

2942

1.52

9.73

2.0

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

174

1065

1.74

9.60

2.5

2.8

ug/g

118.2

172.6

1.50

153

916

(3030905) Polymorphonuclear cells [#/volume] in Blood

175

2.76

9.24

3.2

3.7

e9/l

3.2

3.9

2.14

175

(3025941) Bacteria identified in Stool by Culture

478

2.05

9.18

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

458

2.07

9.13

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

282

2.30

8.47

3.1

3.0

—

(3037522) Nuclear Ab [Titer] in Serum

181

1158

1.67

8.44

1.4

1.3

titre

234.3

365.3

1.34

188

(4038314)

7.57

8.42

1.5

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

234

2.42

8.29

3.2

3.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

193

1262

1.63

8.26

1.4

1.2

iu/ml

22.7

26.4

0.20

378

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.73

8.20

2.5

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

150

920

1.72

8.18

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

139

835

1.75

8.15

3.5

2.9

1.8

0.20

121

767

(3009542) Hematocrit [Volume Fraction] of Blood

1016

9322

1.66

8.15

18.2

13.4

44.1

42.5

7.04

809

7439

(3000012) Reticulocyte production index

5.61

8.03

1.3

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

187

1228

1.62

7.85

2.5

3.6

mmol/l

2.4

0.51

170

1087

(3023520) Reticulocytes [#/volume] in Blood

110

627

1.83

7.69

3.8

3.0

e9/l

77.8

70.8

0.75

479

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

194

1294

1.60

7.62

2.5

1.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

5.66

7.55

2.1

1.9

ug/l

49.6

49.1

0.01

(40768797) Stomach Pathology biopsy report

171

1109

1.63

7.53

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

2.67

7.52

2.9

2.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.39

7.41

2.4

2.0

15.0

14.2

0.12

(3017143) Hepatitis C virus Ab [Presence] in Serum

195

1320

1.57

7.18

2.1

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

465

3736

1.40

7.16

4.5

3.9

—

(3021901) Oxygen saturation in Capillary blood

157

2.60

7.16

3.3

2.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

175

2.51

7.15

2.5

2.4

g/l

144.7

134.3

1.17

131

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

766

6708

1.41

7.01

3.1

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

192

1305

1.56

6.93

1.9

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

312

2349

1.45

6.86

4.7

89.2

88.8

0.12

304

2311

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

4.05

6.64

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

382

1.97

6.63

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

214

2.30

6.56

2.9

2.2

—

(3044640) Blood type and Crossmatch panel - Blood

327

2504

1.42

6.50

2.5

2.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

220

1561

1.50

6.50

1.5

1.4

—

(40758558) Short blood count panel - Blood

285

2139

1.44

6.30

7.4

8.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

168

1136

1.56

6.18

1.3

1.2

u/ml

1.5

8.8

4.41

500

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

336

1.99

6.13

2.3

2.2

—

(3002032) Base excess in Venous blood by calculation

128

813

1.64

6.11

5.5

4.3

mmol/l

1.8

1.9

0.07

108

656

(3011412) CD3 cells [#/volume] in Blood

105

2.81

6.08

3.2

2.7

e9/l

1.1

1.2

0.18

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

212

2.22

5.85

3.0

2.2

—

(3042936) Bacteria identified in Isolate by Culture

188

1320

1.51

5.81

2.3

—

(3002256) Pathology report gross observation

141

931

1.58

5.75

1.5

1.2

—

(4062490)

103

2.76

5.72

1.4

1.2

—

(1002224) Polysomnography panel

107

661

1.68

5.69

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

183

2.29

5.63

1.5

1.7

g/l

0.6

1.0

1.57

138

(3007853) Bacteria identified in Skin by Aerobe culture

159

1087

1.54

5.56

2.2

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

198

2.22

5.49

1.3

1.4

e6/l

5.1

32.3

0.91

144

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

198

2.22

5.49

1.3

1.5

e6/l

183.2

1398.6

0.73

151

(3021447) Carbon dioxide [Partial pressure] in Venous blood

126

819

1.60

5.49

5.3

4.3

kpa

6.0

5.9

0.47

120

797

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

584

1.70

5.41

1.5

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2.04

5.35

1.4

2.6

g/l

3.7

3.8

0.19

187

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2.04

5.35

1.4

2.6

g/l

7.3

7.1

0.27

198

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2.04

5.35

1.4

2.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.67

5.21

4.1

7.5

mg/l

86.7

68.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.72

5.19

3.0

2.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.75

5.12

3.2

2.8

33.3

33.9

0.36

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

245

2.04

5.10

1.5

2.7

g/l

2.9

3.1

0.48

193

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.23

5.10

2.6

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

104

2.63

5.08

1.4

1.2

g/l

6.8

7.3

0.14

(3024139) IgG subclass 3 [Mass/volume] in Serum

104

2.63

5.08

1.4

1.2

g/l

0.4

0.08

(3022313) Gas panel - Capillary blood

434

1.78

5.05

3.2

3.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

155

1076

1.51

5.04

3.3

3.4

umol/l

8.6

9.5

0.19

142

968

(3044290) Cell count panel - Cerebral spinal fluid

186

2.19

5.02

1.3

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

105

2.61

4.99

1.4

1.2

g/l

2.9

3.1

0.16

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

124

2.46

4.91

2.4

2.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

454

1.74

4.87

1.9

2.1

u/l

43.1

39.6

0.75

407

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

187

1358

1.45

4.85

3.4

2.8

e6/l

0.5

0.00

105

747

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

224

2.05

4.76

3.8

3.7

mg/l

36.9

37.4

0.02

175

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

127

857

1.54

4.72

2.5

g/l

0.2

0.30

121

794

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

240

2.00

4.65

10.0

7.6

iu/ml

135.8

725.1

—

(3000492) Spirometry study

167

1201

1.46

4.56

1.6

1.4

—

(3017732) Neutrophils [#/volume] in Blood

596

1.63

4.55

2.6

3.3

e9/l

4.6

4.1

1.30

489

(3034860) Kappa light chains.free [Mass/volume] in Serum

224

2.00

4.40

3.8

3.7

mg/l

70.1

93.4

0.27

174

(3000991) Gas panel - Venous blood

118

796

1.54

4.40

12.0

—

(3017704) Immunofixation for Urine

3.36

4.33

2.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

233

1.97

4.30

1.3

1.5

ug/g

350.4

265.3

2.25

135

(3044927) Protein electrophoresis panel - Urine

2.81

4.30

1.3

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.98

4.29

3.3

2.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

193

1442

1.40

4.27

3.4

2.7

e6/l

0.5

0.9

2.00

110

825

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

3.17

4.21

1.2

mmol/l

12.4

12.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.64

4.21

1.1

1.0

—

(3016750) Collection duration of Urine

2.89

4.07

2.3

min

506.5

502.7

0.04

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

2.59

4.06

1.2

pmol/l

309.5

271.5

0.20

(36660697) Celiac disease serology panel - Serum

615

1.57

4.02

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

133

2.21

3.82

4.8

4.4

2.4

1.5

0.40

118

(3021879) Hepatitis B virus core Ab [Presence] in Serum

125

880

1.47

3.82

1.8

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.21

3.78

2.5

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

248

1967

1.33

3.75

2.5

—

(3037756) Immunofixation for Serum or Plasma

148

2.12

3.71

2.9

1.6

—

(4024509)

3.14

3.65

1.4

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

101

687

1.51

3.65

2.0

2.6

ml/min/173m2

61.9

72.3

1.40

234

(3048929) Epstein Barr virus Ab [Presence] in Serum

361

1.70

3.60

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

361

1.70

3.60

1.5

1.8

g/l

1.5

0.19

312

(3028707) Methadone [Presence] in Urine by Screen method

249

1.84

3.58

3.3

4.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

286

1.78

3.57

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

171

2.02

3.56

4.3

3.6

—

(3003396) Base excess in Arterial blood by calculation

144

1058

1.41

3.51

10.6

10.7

mmol/l

1.0

0.02

127

827

(21494890) Protein electrophoresis panel - 24 hour Urine

2.56

3.30

1.5

2.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

136

2.08

3.24

1.1

u/ml

2.2

2.1

0.04

(3004451) EKG impression Narrative

2.69

3.23

1.1

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

124

902

1.42

3.21

2.4

1.8

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.75

3.16

3.1

1.9

u/l

188.7

204.5

0.38

(3000093) Morphology [Interpretation] in Blood Narrative

2.40

3.07

1.1

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

218

1745

1.31

3.06

3.5

3.7

ng/l

748.3

663.8

0.07

165

1342

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.03

3.05

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.03

3.05

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.47

3.05

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

196

1.86

3.05

1.6

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

204

1.84

3.02

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

2.49

2.96

1.9

2.4

—

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

163

1.93

2.92

2.5

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

368

1.61

2.89

2.2

1.8

mg/l

5.1

4.6

0.07

265

(3028300) Cannabinoids [Presence] in Urine

621

1.47

2.89

2.6

2.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

147

1123

1.35

2.85

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.31

2.85

2.4

2.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.31

2.85

2.4

2.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.31

2.85

2.4

2.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

239

1.74

2.81

1.1

u/ml

0.7

5.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

241

1976

1.28

2.80

2.0

1.5

0.26

216

1780

(3037121) Protein [Mass/volume] in Urine

301

1.66

2.78

3.6

4.1

g/l

0.3

0.02

178

(1001926) Buprenorphine [Presence] in Urine by Screen method

477

1.52

2.77

2.6

3.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

124

2.04

2.77

2.7

1.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

8.36

2.75

3.0

3.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

111

2.09

2.74

2.5

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

612

1.46

2.72

2.6

2.7

—

(4010399)

604

1.46

2.71

1.3

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

175

1.85

2.70

1.1

u/ml

1.7

1.6

0.02

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

258

1.69

2.67

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

606

1.45

2.67

2.7

2.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.81

2.65

3.0

3.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.81

2.65

3.0

3.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.81

2.65

3.0

3.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.81

2.65

3.4

2.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.81

2.65

3.2

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.81

2.65

3.0

3.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

123

925

1.37

2.64

2.6

1.8

—

(3016879) Cocaine [Presence] in Urine

575

1.46

2.62

2.6

2.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

107

2.08

2.58

1.5

1.3

—

(3027008) Opiates [Presence] in Urine

620

1.44

2.56

2.6

2.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

301

1.62

2.54

2.3

2.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

311

1.60

2.47

3.3

2.9

g/l

3.8

3.7

0.13

298

(3011648) Oxygen content in Venous blood

2.10

2.44

3.1

2.3

13.3

11.6

0.68

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

131

1.93

2.42

1.0

1.2

—

41.6

—

(3004775) Volume in Urine collected for unspecified duration

2.19

2.41

2.2

2.3

868.7

614.9

1.18

(3024928) Oxygen saturation in Venous blood

213

1.71

2.38

4.9

3.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

183

1.77

2.37

1.1

u/ml

2.9

7.6

1.67

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

1.91

2.37

2.3

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

104

2.04

2.37

2.6

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

229

1.68

2.35

2.1

3.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

277

1.61

2.31

1.7

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

238

1.66

2.31

1.8

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

155

1.83

2.31

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.39

2.29

3.2

u/ml

676.9

1237.0

0.70

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.70

2.28

1.4

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.04

2.27

5.2

—

(4094501)

327

1.55

2.25

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

127

986

1.32

2.24

5.3

4.2

27.2

28.7

0.88

101

716

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

248

1.63

2.24

1.2

1.9

nmol/l

1.1

0.9

1.11

221

(3011288) Drugs identified in Urine by Screen method

393

1.50

2.23

4.6

4.0

—

(3045142) Bone marrow Pathology biopsy report

107

1.98

2.21

1.7

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

165

1.78

2.20

1.1

1.2

—

3.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

116

892

1.33

2.19

1.6

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

168

1359

1.28

2.18

2.1

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

266

1.60

2.17

2.8

2.3

ug/min

341.2

143.7

0.45

158

(3019225) pH of Specimen

692

1.37

2.17

5.3

4.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.46

2.10

1.1

iu/ml

162.1

275.1

0.80

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

138

1.83

2.10

2.7

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

214

1.66

2.08

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.09

2.07

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

117

1.90

2.07

1.2

1.1

mmol/l

7.0

0.00

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.41

2.03

3.2

2.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

632

1.37

2.01

13.5

13.3

0.6

0.7

1.08

626

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.95

1.96

1.1

—

(3015183) Erythrocyte sedimentation rate

2.20

1.95

1.1

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.56

1.94

1.6

2.6

ng/l

138.9

154.8

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.76

1.93

16.7

11.1

umol/l

0.5

0.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

219

1.62

1.92

1.7

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.13

1.92

1.9

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.58

1.92

3.4

3.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.58

1.92

3.4

3.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.01

1.90

3.3

3.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

228

1.60

1.89

1.9

1.5

u/ml

106.4

117.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

129

1.80

1.86

1.3

1.5

promille

1.4

1.5

0.12

102

(3048879) Bone marrow aspiration report

2.87

1.86

4.1

2.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.40

1.85

1.2

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.54

1.84

1.0

2.6

mmol/l

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.51

1.84

3.4

3.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

111

872

1.30

1.83

2.8

2.9

u/l

31.5

97.7

0.70

789

(3022217) INR in Platelet poor plasma by Coagulation assay

129

1034

1.28

1.83

16.5

20.8

inr

1.0

1.2

6.31

143

(3023410) Appearance of Cerebral spinal fluid

1.93

1.80

1.6

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

628

1.35

1.78

3.0

2.8

ng/l

187.3

160.1

0.20

553

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.95

1.75

2.8

3.1

38.5

39.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

208

1771

1.21

1.72

3.5

3.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.30

1.70

2.5

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

203

1.59

1.69

1.2

1.1

u/ml

4.2

1.9

0.30

(40768443) Skin Pathology biopsy report

334

1.46

1.68

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.59

1.66

1.4

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

2.81

1.65

25.7

9.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

229

1.54

1.64

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.26

1.64

2.5

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

395

1.41

1.63

4.1

mmol/l

25.8

25.0

0.98

382

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

542

1.35

1.62

14.7

14.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

174

1.62

1.1

u/ml

0.5

3.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.58

1.61

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.58

1.61

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.01

1.58

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

476

1.36

1.56

2.1

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.28

1.53

2.7

2.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

283

1.46

1.51

1.6

1.9

—

(3028433) Virus identified in Specimen by Culture

2.60

1.51

1.0

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1.87

1.50

2.7

4.7

52.6

57.8

0.31

(40757373) Influenza virus identified in Isolate

2.87

1.50

1.2

2.4

—

(3019060) Gas panel - Arterial blood

593

1.32

1.50

7.8

6.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

131

1.69

1.50

1.1

1.2

—

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

259

1.48

1.49

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

203

1749

1.19

1.49

3.4

3.2

kg/l

1.0

0.48

212

(4035726)

639

1.30

1.48

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

117

1.72

1.45

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.13

1.44

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

253

1.48

1.44

1.3

1.2

u/ml

286.8

278.3

0.06

157

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

125

1.69

1.44

1.2

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.13

1.44

1.0

2.4

mmol/l

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

110

1.74

1.43

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

135

1.64

1.36

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

290

1.43

1.36

1.7

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

497

1.33

1.35

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

241

1.47

1.33

1.3

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.98

1.33

1.2

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

184

1.53

1.32

1.3

1.5

—

(3000330) Specific gravity of Urine by Test strip

309

1.41

1.32

3.4

3.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

242

1.46

1.31

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

242

1.46

1.31

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.36

1.29

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.36

1.29

3.4

4.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

146

1.59

1.26

1.0

1.1

u/ml

4.3

3.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

115

1.66

1.25

1.1

—

(3049717) Cytology report of Urine Cyto stain

347

1.37

1.24

2.9

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.23

1.24

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

155

1.56

1.23

1.0

1.1

u/ml

0.4

2.8

—

(3003694) ABO and Rh group [Type] in Blood

278

2496

1.15

1.23

1.4

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

246

1.44

1.22

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

124

1.62

1.21

3.4

2.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.31

1.19

1.5

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.11

1.18

1.3

2.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

157

1.54

1.18

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

157

1.54

1.18

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

282

1.40

1.17

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.78

1.17

1.3

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

257

1.41

1.16

3.6

3.5

umol/l

44.5

36.9

0.78

227

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.73

1.15

2.6

2.3

—

(3051611) Lipemic interference index of Serum or Plasma

1.81

1.15

1.9

3.5

—

(3006462) Nitrate [Presence] in Urine

2.51

1.15

2.4

2.0

—

(3020891) Body temperature

379

1.33

1.14

7.7

5.2

—

(4027681)

1.91

1.12

1.2

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.01

1.12

1.3

1.7

—

3.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

389

1.33

1.12

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.71

1.11

2.3

2.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.71

1.11

2.4

3.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.96

1.09

7.8

3.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.96

1.09

1.3

3.0

—

49643.7

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.19

1.08

1.4

1.5

—

(40761535) Cells panel - Urine sediment

660

1.24

1.08

3.1

—

(44790048)

113

1.60

1.06

2.6

1.9

—

(44790047)

113

1.60

1.06

2.6

1.9

—

(44790049)

113

1.60

1.06

2.6

1.9

—

(44806118)

113

1.60

1.06

2.6

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

146

1.52

1.03

1.6

1.9

—

(40768446) Kidney Pathology biopsy report

1.96

1.03

1.8

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

255

1.38

1.03

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.28

1.03

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

130

1.55

1.03

1.0

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

171

1.47

1.03

2.8

2.5

titre

640.0

1491.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.92

1.02

2.9

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.92

1.02

2.9

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

1.89

1.01

1.5

1.2

nmol/l

159.5

150.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.88

1.00

2.2

1.9

—

(21494434) Karyotype in Bone marrow

1.72

0.99

1.2

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

134

0.52

0.99

24.1

14.6

nmol/l

827.9

819.1

—

129

(4211845)

2.18

0.98

2.4

2.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.18

0.98

2.0

1.3

100.8

104.3

—

(3023419) Bacteria identified in Sputum by Culture

124

1.54

0.97

2.9

3.0

—

(3016018) Differential panel - Cerebral spinal fluid

116

1.56

0.97

1.3

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

182

1.44

0.96

1.8

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

101

1.59

0.94

1.4

1.7

66.1

61.9

—

(3022621) pH of Urine by Test strip

429

1.27

0.91

2.5

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

342

1.30

0.88

3.0

2.5

90.1

91.0

0.10

329

(4268621)

119

1.52

0.88

2.7

2.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

186

1.41

0.87

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.01

0.87

1.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

132

1157

1.16

0.84

1.8

1.6

—

(44813793)

1.78

0.84

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

129

1.48

0.83

2.2

1.9

—

(4146454)

112

0.53

0.83

3.7

2.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.65

0.81

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

216

1.35

0.79

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

313

1.29

0.78

3.3

3.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

279

1.30

0.76

1.2

1.1

—

0.7

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1.70

0.75

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

280

1.29

0.75

9.3

8.0

mmol/l

1.4

1.3

0.34

243

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

308

1.28

0.73

4.3

3.0

u/ml

0.3

0.48

164

(3047189) Immunofixation for 24 hour Urine

1.80

0.72

1.3

1.7

—

(3051651) Icteric interference index of Serum or Plasma

1.67

0.72

2.1

3.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

309

1.27

0.71

1.6

1.7

—

(3045414) Leukocytes [Presence] in Urine

318

1.27

0.71

1.7

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.86

0.68

5.4

4.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

127

1.42

0.68

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

127

1.42

0.68

2.4

2.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

232

1.30

0.66

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

232

1.30

0.66

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.54

0.65

1.3

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

468

1.21

0.65

2.5

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.73

0.64

13.0

8.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.73

0.64

1.8

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.52

0.62

9.2

10.5

u/ml

29.2

159.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.64

0.62

1.8

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.64

0.62

1.8

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.64

0.62

3.0

1.3

ug/l

11.9

8.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.64

0.62

1.8

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

244

1.28

0.61

1.1

1.4

—

(3044941) Cell count panel - Synovial fluid

139

1.37

0.60

1.3

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.57

0.60

1.8

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.57

0.60

1.8

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.57

0.60

1.8

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

0.59

0.0

4.0

—

4470.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.51

0.58

1.3

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.67

0.56

1.5

1.2

—

65.0

—

(3042733) HLA Ab [Presence] in Serum

1.46

0.56

8.5

4.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

230

1.27

0.55

1.4

1.3

miu/ml

123.6

184.8

0.47

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.62

0.55

1.0

1.2

—

(3014271) Vancomycin [Susceptibility]

1.62

0.55

2.3

2.6

—

(3020650) Glucose [Presence] in Urine

1.58

0.54

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.50

0.54

1.8

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.42

0.54

2.2

1.7

—

(3005570) Glucose [Moles/volume] in Urine

1.43

0.52

1.8

1.4

—

(4198724)

1.45

0.52

1.3

4.2

—

(40768441) Liver Pathology biopsy report

1.39

0.50

1.0

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.47

0.50

2.0

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.50

0.49

1.2

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

101

1.39

0.49

2.1

1.7

—

(3036489) Thrombin time

372

1.19

0.49

3.1

2.3

21.4

21.6

0.15

327

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.49

0.47

2.9

ug/l

14.7

537.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

102

1.38

0.47

2.2

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

102

1.38

0.47

2.1

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

102

1.38

0.47

2.2

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

102

1.38

0.47

2.1

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

164

1.29

0.46

4.5

3.8

—

(3003181) Sodium [Moles/volume] in Urine

120

1.34

0.46

1.4

1.2

mmol/l

75.2

65.7

0.29

(4133840)

1.40

0.45

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.3

—

(40768806) Pleura Pathology biopsy report

1.43

0.41

1.5

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.36

0.41

1.5

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

342

1.18

0.41

7.4

4.7

mmol/l

1.3

1.4

0.25

336

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.52

0.41

13.0

7.9

—

(40765096) Chromosome analysis panel by Banding

1.52

0.41

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.41

0.0

2.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.41

0.0

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

141

1.28

0.40

1.3

1.8

iu/l

2.6

5.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

485

1.14

0.39

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

178

1.24

0.39

1.6

1.2

u/ml

2.4

5.0

—

(40768795) Lymph node Pathology biopsy report

1.34

0.36

1.2

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

1.40

0.35

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

302

1.16

0.34

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

163

1.23

0.34

1.4

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

127

1.26

0.33

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

127

1.26

0.33

1.3

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

191

1.21

0.33

1.1

g/l

1.4

1.5

0.71

172

(3010144) Erythrocytes [#/volume] in Synovial fluid

0.68

0.33

1.0

1.2

e6/l

13103.2

60014.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.28

0.32

9.3

6.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.31

0.32

1.3

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.35

0.31

1.3

1.0

—

(3021788) Differential panel - Synovial fluid

148

1.22

0.29

1.4

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

185

1.19

0.29

1.3

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.28

0.28

2.9

4.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.30

0.28

1.3

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.30

0.28

1.3

1.0

—

(3012441) Differential panel - Pleural fluid

1.25

0.27

1.6

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

168

1.19

0.27

3.5

mmol/l

1.4

1.7

1.40

163

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

196

1.18

0.27

1.5

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.25

0.25

1.3

1.1

—

(3008898) HLA-B27 [Presence]

340

0.88

0.25

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

157

0.83

0.22

1.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.22

0.22

1.4

1.1

miu/ml

1366.8

1408.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.21

0.0

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

41.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3034426) Prothrombin time (PT)

1.16

0.21

2.0

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

173

1.16

0.21

5.0

3.0

mg/l

18.7

25.8

0.45

111

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.21

0.0

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.20

0.0

2.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

394

1.09

0.19

1.6

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.18

0.19

2.0

1.6

—

(3024932) HLA-DR beta [Type]

1.15

0.19

1.2

1.1

—

(3024471) HLA-A [Type]

1.13

0.18

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.17

0.17

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.21

0.17

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.13

0.17

2.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.08

0.14

1.6

g/l

31.2

33.3

—

(3004616) Nuclear Ab [Presence] in Serum

1.08

0.14

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.18

0.14

1.5

g/l

0.9

1.1

0.59

(3000475) Leukocytes [#/volume] in Synovial fluid

212

1.09

0.10

1.3

1.6

e6/l

19958.1

16496.7

0.15

160

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

101

1042

0.97

0.10

9.8

6.4

—

(3009871) Measles virus Ab [Titer] in Serum

1.06

0.09

1.4

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.06

0.09

1.4

2.1

—

260.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.09

0.09

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

165

1.09

0.08

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.05

0.08

2.5

5.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.82

0.08

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.82

0.08

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.09

0.08

1.7

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.84

0.07

1.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.04

0.07

1.6

1.7

—

(4034850)

304

0.95

0.05

17.8

9.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.11

0.05

1.6

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

327

1.04

0.05

1.7

1.6

iu/ml

0.0

0.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

170

0.94

0.04

1.9

1.2

u/ml

1.7

4.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

141

1.06

0.03

1.3

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.08

0.02

3.6

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.08

0.02

1.8

3.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

841

1.01

0.01

2.7

2.2

ug/l

10.2

10.1

0.01

772

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

114

0.96

0.00

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

708

1.00

0.00

4.7

5.1

ug/l

21.0

24.0

0.07

594

(4306422)

191

0.99

0.00

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

166

1665

1.00

0.00

1.3

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.02

0.00

1.0

1.3

—

3.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.8

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

3.1

—

(3017569) Oxygen content in Arterial blood

1.02

0.00

1.2

3.1

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

0.0

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.9

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.0

—

(3024263) Appearance of Synovial fluid

0.91

0.00

1.4

1.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.0

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.1

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.99

0.00

1.3

1.4

mmol/l

8.2

6.3

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

11.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.3

—

511.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

12.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.00

0.00

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

41.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.8

—

1.3

—

(4212803)

0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

7.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3025315) Body weight

0.00

0.0

2.7

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1696.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

3.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_TESTICHYPO and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
E4_TESTICHYPO	1.58 [1.3, 1.91]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 243 out of 2410 males with E4_TESTICHYPO died.

Mortality risk

Mortality risk for people of age

years, who have E4_TESTICHYPO.

N-year risk	Females	Males
1	No data	0.265%
5	No data	1.557%
10	No data	4.102%
15	No data	7.786%
20	No data	13.192%

Relationships between endpoints

↥

Index endpoint: E4_TESTICHYPO – Testicular hypofunction

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Testicular hypofunction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints